[ivory-search id="184" title="Recordati AJAX Search Form"]

Item Tag: 116/086

2025 Pokemon Joltik White Flare 116/086 Illustration Rare Alt Art Holo Raw NM

The 2025 Pokemon Joltik White Flare 116/086 Illustration Rare Alt Art Holo Raw NM card is a highly sought-after collectible from the Pokémon TCG game. Featuring a stunning holographic design and full art illustration, this card is a rare find for collectors. With a unique white flare attribute and manufactured by The Pokémon Company, this basic stage Pokémon card is a valuable addition to any card collection. This card was signed by Adam Paquette in a hard-signed format and authenticated by James Spence Authentication, adding to its rarity and authenticity.

2025 Pokemon Joltik White Flare 116/086 Illustration Rare Alt Art Holo Raw NM

The 2025 Pokemon Joltik White Flare 116/086 Illustration Rare Alt Art Holo Raw NM card is a highly sought-after collectible from the Pokémon TCG game. Featuring a stunning holographic design and full art illustration, this card is a rare find for collectors. With a unique white flare attribute and manufactured by The Pokémon Company, this basic stage Pokémon card is a valuable addition to any card collection. This card was signed by Adam Paquette in a hard-signed format and authenticated by James Spence Authentication, adding to its rarity and authenticity.

Mega Greninja ex – 116/086 – ME04: Chaos Rising

The Mega Greninja ex – 116/086 – ME04: Chaos Rising card is a highly sought-after Pokémon TCG collectible from The Pokémon Company. This Stage 2 Pokémon card featuring Greninja has a rarity of Special Illustration Rare and a holo finish, making it a valuable addition to any collector’s deck. With its striking full art design and 350 HP, this English-language card is a must-have for fans of the Pokémon franchise.

Mega Greninja ex SIR 116/086 Chaos Rising Special Illustration Rare Pokemon NM

The Mega Greninja ex SIR 116/086 Chaos Rising Special Illustration Rare Pokemon card is a highly sought-after collectible in the Pokémon TCG game. With its water attribute, holo finish, and special illustration, this card is a valuable addition to any collector’s deck. Originating from the United States, this rare card features the powerful Greninja Ex character with a unique design that sets it apart from other cards in the game. Perfect for fans of Pokémon and collectors of rare cards, this Mega Greninja ex card is a must-have for any serious player.

Mega Greninja ex 116/086 Me04: Chaos Rising NM/M

The Mega Greninja ex 116/086 Me04: Chaos Rising NM/M is a highly sought-after Pokémon Trading Card Game card manufactured by The Pokémon Company. This Special Illustration Rare card features Mega Greninja Ex with a card number of 116/086 and a holo finish. With a high HP of 350, it is a valuable addition to any Pokémon TCG collection especially for fans of Greninja and collectors of EX cards. Illustrated by Susumu Maeya, this Stage 2 Pokémon card is in English language and a must-have for any serious collector.

Mega Greninja ex 116/086 Me04: Chaos Rising Holo

The product is a special illustration rare Mega Greninja ex 116/086 Me04: Chaos Rising Holo card from the Pokémon TCG. This English language card has an HP of 350 and is illustrated by Susumu Maeya. As a Stage 2 Pokémon card manufactured by The Pokémon Company, it belongs to the EX specialty category, making it a sought-after collectible for fans and collectors of the game. With its striking design and rarity, this Mega Greninja ex card is a valuable addition to any Pokémon TCG collection.

Mega Greninja EX 116/086 XY Full Art Holo Ultra Rare ENG *Very Clean*

The Mega Greninja EX 116/086 XY Full Art Holo Ultra Rare card from the 2016 Pokemon TCG set features a powerful 350 HP character with an attack power of 120+. This English language card showcases the popular Greninja character as a Stage 2 Pokemon with a unique full art design by Susumu Maeya. As a collectible card game item made of card stock, this ultra rare card is highly sought after by collectors and players alike.

Mega Greninja ex – 116/086 – Chaos Rising – NM/M VERY GRADABLE

The Mega Greninja ex card from the Chaos Rising set is a special illustration rare Pokemon card manufactured by Nintendo in 2026. Near Mint/Mint, very gradable and Gem candidate. Bid with confidence. Happy to provide additional photos and/or video. Will ship securely within a top loader with plenty of bubble wrapping and protection.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site
Recordati for the planet
A clean environment is essential for people’s well-being: the health of the planet and the health of people is tightly interconnected. Environmental elements, such as air, water, land and climate, all have an impact on the well-being of humans. Placing a focus on people’s health and being sustainable therefore also means prioritising environmental protection and a responsibility towards future generations. This is why the Group ensures that it conducts business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the expectations of stakeholders.
Recordati for the community
We believe that contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely the fulfilment of company obligations or professional duty, but rather a moral imperative, an essential part of a healthy business capable of growth but at the same time able to support and develop the community in which it operates and make its employees proud.
Value and diversity of our people
At Recordati, we believe in equal opportunities and we guarantee that everyone can achieve their potential. We see diversity as a value and will not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics. At Recordati, we work hard to create a safe and inclusive work environment, where we all have our rights to physical and psychological integrity respected on a daily basis, as well as our right to freedom of opinion and association. We recognise that we each have a role to play in the success of our business and we implement staff development policies through which everyone’s contribution and achievements can be appropriately rewarded.
Multiple opportunities
Recordati is uniquely structured to bring treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research and development, chemical and finished product manufacturing through to commercialisation and licensing.
Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is Managing Director and General Manager for EMEA at Recordati Rare Diseases, leading the European and Middle Eastern Commercial Operations. He is responsible for Marketing, Medical, Market Access, Regulatory, Manufacturing and Logistics, as well as the enabling functions to support the business, including Compliance and Quality.

 

He joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. In such a role he has been responsible for driving the growth of the rare disease portfolio at Recordati, with his duties ranging from business development to strategic marketing and pipeline project management.

 

Before he joined Recordati, he held senior business and corporate development roles at Chiesi Farmaceutici and Menarini Group where he executed several key asset deals and transactions.

Luigi gained a degree in Economics from the University of Florence and a Master’s degree in Business Innovation from Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region, Head of Global Endocrinology Franchise

Bruno Parenti is Head of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific and Russia. He has been in this position since 2011, where he spearheaded the expansion of operations around the globe. He recently assumed the additional role of Head of Global Endocrinology Franchise, establishing the new HQ in Basel and building a dedicated organization.

 

Prior to these positions, Bruno spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

 

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

 

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site